This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of California. Active years: 2022.
Company Filing History:
1 out of 953 
1 out of 15,977 
Years Active: 2022
Title: Innovations in Prostate Cancer Treatment by Wei Lou
Introduction
Wei Lou is an accomplished inventor based in Davis, CA (US). He has made significant contributions to the field of cancer treatment, particularly focusing on metastatic prostate cancer. His innovative approaches aim to address challenges associated with drug-resistant forms of the disease.
Latest Patents
Wei Lou holds a patent for a groundbreaking invention titled "Treatment of metastatic prostate cancer." This patent presents new compositions and methods for treating prostate cancer, including drug-resistant variants such as anti-androgen drug-resistant and castration-resistant prostate cancer (CRPC). The compositions include pharmaceutical formulations that feature an AR-V7 inhibitor, such as niclosamide, and an AKR1C3 inhibitor, such as indomethacin. The methods outlined in the patent involve administering these inhibitors to effectively treat patients suffering from prostate cancer.
Career Highlights
Throughout his career, Wei Lou has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His work has been instrumental in advancing treatment options for prostate cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Wei Lou has collaborated with notable colleagues, including Allen C Gao and Chengfei Liu. These partnerships have contributed to the development of innovative solutions in cancer treatment.
Conclusion
Wei Lou's contributions to the treatment of metastatic prostate cancer highlight his role as a leading inventor in the field. His innovative approaches and collaborations continue to pave the way for advancements in cancer therapies.